Intravenous Therapy Solutions Industry Set to Achieve $19.33 Billion Milestone by 2029 | Steady 10.1% CAGR

Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments.

What Is the Long-Term Growth Forecast for the Intravenous Therapy Solutions Market Size 2025?
In the past few years, there has been a significant increase in the intravenous therapy solutions market size. It is projected to expand from $11.95 billion in 2024 to $13.17 billion in 2025, with a compound annual growth rate (CAGR) of 10.3%. This growth throughout the historical era is due to factors such as increased hospital admissions, an escalation in surgical operations, a rising number of dehydration cases, an elevated occurrence of chronic diseases, and the enhancement of healthcare infrastructure access.

What CAGR is Forecasted for the Intravenous Therapy Solutions Market Through 2029?
Anticipated to experience swift expansion in the coming few years, the market size for intravenous therapy solutions is projected to climb up to $19.33 billion in 2029, boasting a compound annual growth rate (CAGR) of 10.1%. This surging advancement during the forecast period is linked to numerous factors such as the increase in the aging population, the broadening of home healthcare services, the surging requirement for swift rehydration remedies, an escalating occurrence of gastrointestinal issues, and the augmented employment of single-use IV elements. Future trends within this forecast period encompass progress in IV drug delivery systems, a transition to home-based IV therapy, amalgamation of smart infusion pumps, expansion in biologic and specialty drug infusions, and an increased inclination for personalized IV nutrition therapy.

Explore The Complete Report Now:
https://www.thebusinessresearchcompany.com/report/intravenous-therapy-solutions-global-market-report

What Are the Critical Factors Driving Intravenous Therapy Solutions Market Development?
The intravenous therapy solutions market is anticipated to grow due to a surge in popularity for minimally invasive therapies. These treatments entail minimum incisions or insertions into the body, facilitating quicker recovery and lessening the risk of complications. The appeal of minimally invasive therapies lies in their ability to alleviate postoperative discomfort, leading to quicker rehabilitation of patients and overall enhanced comfort during the healing phase. Intravenous therapy solutions are a crucial part of minimally invasive therapies as they enable essential fluids, medications, and nutrients to be efficiently delivered directly into the patient's bloodstream. This helps ensure superior patient care and expedited recovery. For example, in June 2024, the American Society of Plastic Surgeons, a not-for-profit organization based in the US, reported a 7% rise in minimally invasive procedures in 2023, outdoing surgical procedures by 2%. Hence, the increase in preference for minimally invasive therapies is propelling the expansion of the intravenous (IV) therapy solutions market.

Get Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25802&type=smp

How Does the Intravenous Therapy Solutions Market Break Down Across Major Segments?
The intravenous therapy solutions market covered in this report is segmented -

1) By Product Type: Crystalloids, Colloids, Blood Products, Other Product Types
2) By Application: Fluid And Electrolyte Imbalance, Nutritional Support, Medication Administration, Blood Transfusion, Other Applications
3) By End-User: Hospitals, Clinics, Ambulatory Surgical Centers, Home Care Settings, Other End-Users

Subsegments:
1) By Crystalloids: Normal Saline (0.9% Sodium Chloride), Half Normal Saline (0.45% Sodium Chloride), Lactated Ringer's Solution, Dextrose Solutions, Hypertonic Saline
2) By Colloids: Albumin, Dextran, Hydroxyethyl Starch (HES), Gelatin
3) By Blood Products: Packed Red Blood Cells (PRBCs), Platelets, Fresh Frozen Plasma (FFP), Cryoprecipitate
4) By Other Product: Intravenous Immunoglobulins (IVIG), Parenteral Nutrition Solutions, Specialty Intravenous Drugs And Additives

What Are the Major Trends Transforming the Intravenous Therapy Solutions Industry?
Key players in the intravenous therapy solutions market are concentrating on the creation of novel solutions such as ready-to-use drug infusion systems to improve treatment efficacy and cut down on preparation time in clinical environments. This essentially points to intravenous (IV) medications that are pre-mixed and pre-labeled, packaged in standard doses and eliminating the need for compounding or dilution onsite. For example, in May 2024, B. Braun Medical Inc., a manufacturing firm based in the United States, unveiled an IV anticonvulsant solution that's ready-to-use: Levetiracetam in Sodium Chloride Injection. This product, specifically formulated for seizure treatment, is available in standardized volumes and concentrations, removing the necessity for dilution or compounding at care facilities. The Levetiracetam IV blend comes pre-mixed in a flexible container, which guarantees precise dosage, lessens contamination risks, and offers increased convenience for medical professionals in emergency and inpatient situations.

Customize Your Insights And Get The Full Report Here:
https://www.thebusinessresearchcompany.com/customise?id=25802&type=smp

Which Players Are Driving Innovation in the Intravenous Therapy Solutions Market?
Major companies operating in the intravenous therapy solutions market are Pfizer Inc., Johnson & Johnson, Otsuka Pharmaceutical Co. Ltd., Baxter International Inc., Fresenius Kabi AG, Grifols S.A., Terumo Corporation, Dr. Reddy's Laboratories Limited, Sichuan Kelun Pharmaceutical Co. Ltd., Teleflex Incorporated, Hikma Pharmaceuticals PLC, ICU Medical Inc., Biocon Limited, B. Braun Melsungen Aktiengesellschaft, JW Life Science Corporation, AdvaCare Pharma USA, Soxa Formulations & Research Pvt. Ltd., Vifor Pharma Management Ltd., Aetos Pharma Private Limited, LXIR Medilabs Private Limited

Which Regions Are Driving Global Intravenous Therapy Solutions Market Expansion?
North America was the largest region in the intravenous therapy solutions market in 2024. The regions covered in the intravenous therapy solutions market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out to Us Speak With Our Expert: Saumya Sahay
Americas +1 310-496-7795,
Asia +44 7882 955267 & +91 8897263534,
Europe +44 7882 955267
Email: saumyas@tbrc.info
The Business Research Company - www.thebusinessresearchcompany.com
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.